Search results
Alzheimer's: 4 lifestyle changes may help improve or prevent decline
Medical News Today· 19 hours agoAlzheimer’s disease is a progressive disease that affects thought and functioning and is the most...
Alzheon secures $100m to advance Alzheimer’s disease treatment
Pharmaceutical Technology via Yahoo Finance· 1 day agoClinical-stage biopharmaceutical company Alzheon has secured $100m in a Series E funding round to...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab
CNN via AOL· 3 days agoOn Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse Eli Lilly’s drug donanemab, a monoclonal antibody designed to slow the progression of early ...
Eli Lilly's Alzheimer's Drug Gains Unanimous FDA Panel Backing
Verywell Health via Yahoo News· 3 days agoAn FDA advisory panel endorsed donanemab, Eli Lilly’s monoclonal antibody drug designed to slow the...
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab
Zacks via Yahoo Finance· 2 days agoIf Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by...
Alzheimer's drug that can slow disease gets backing from FDA advisers
Associated Press Finance via Yahoo Finance· 4 days agoA closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on...
A look at Alzheimer’s Disease and how to care for your loved one
KNOE Monroe LA· 1 day agoAccording to the Alzheimer’s Association, over 95,000 people in Louisiana are living with Alzheimer’s disease. < ...
Alzheimer’s Foundation of America encouraged by new drug closer to FDA approval
WBRC Fox 6 Birmingham· 2 days agoFederal health advisers are recommending a new Alzheimer’s drug from Eli Lilly that slows the...
New Alzheimer’s treatment could bring hope to local families impacted by the disease
WPXI via Yahoo News· 1 day agoEli Lilly developed a drug called Donanemab. “This is potentially the third FDA-approved medication for the actual treatment of the underlying biology of Alzheimer’
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel
Forbes· 3 days agoA Food and Drug Administration expert panel of advisors voted 11-0 yesterday to recommend that the...